Shen Y, Liu Q, Li H, Liu W, et al. Whole-exome sequencing identifies FANC heterozygous germline mutation as an adverse factor for immunosuppressive therapy in Chinese aplastic anemia patients aged 40 or younger: a single-center retrospective study. Ann Hematol 2023 Jan 9. doi: 10.1007/s00277-023-05086.
PMID: 36622392